# Ventaira Pharmaceuticals

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/ventaira-pharmaceuticals

- Industry: Pharmaceuticals
- Headquarters: Columbus, US
- Total disclosed funding: $36M
- Latest round: Series C (Apr 5, 2005)
- Investors on record: 9

## About

Founded in 1997, based in Columbus, Ohio, Ventaira Pharmaceuticals (f/k/a BattellePharma) is a specialty pharmaceutical company. It develops pharmaceutical products for inhalation.

## Funding rounds

- Series C, Apr 5, 2005, $14M — Novitas Capital, Safeguard Scientifics, TL Ventures, Fletcher Spaght Ventures, Reservoir Venture Partners, Battelle Ventures, James Richardson & Sons, Battelle Memorial Institute
- Series B, Feb 19, 2003, $22M — TL Ventures, Fletcher Spaght Ventures, Battelle Memorial Institute, Merlin BioMed Group

## Investors

- TL Ventures (https://capitalatlas.ai/funds/tl-ventures) — Series B, Series C
- Fletcher Spaght Ventures (https://capitalatlas.ai/funds/fletcher-spaght-ventures) — Series B, Series C
- Battelle Memorial Institute — Series B, Series C
- Merlin BioMed Group — Series B
- Novitas Capital (https://capitalatlas.ai/funds/novitas-capital) — Series C
- Safeguard Scientifics (https://capitalatlas.ai/funds/safeguard-scientifics) — Series C
- Reservoir Venture Partners (https://capitalatlas.ai/funds/reservoir-venture-partners) — Series C
- Battelle Ventures (https://capitalatlas.ai/funds/battelle-ventures) — Series C
- James Richardson & Sons — Series C